The neural circuit basis of Rett syndrome

Frontiers in Biology

Volumn 7, Issue 5, 2012, Pages 428-435

  Goffin, Darren ^a  

^a Joe)   (United States)

Author keywords

ERP; MeCP2; neural circuit; Rett syndrome; synapse

Indexed keywords

EID: 84867425331     PISSN: 16747984     EISSN: 16747992     Source Type: Journal    
DOI: 10.1007/s11515-012-1248-5     Document Type: Review

References (62)

1. Amir R E, van den Veyver I B, Wan M, Tran C Q, Francke U, Zoghbi H Y (1999). Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet, 23(2): 185-188.
2. Armstrong D D (2005). Neuropathology of Rett syndrome. J Child Neurol, 20(9): 747-753.
3. Asaka Y, Jugloff D G M, Zhang L, Eubanks J H, Fitzsimonds R M (2006). Hippocampal synaptic plasticity is impaired in the Mecp2-null mouse model of Rett syndrome. Neurobiol Dis, 21(1): 217-227.
4. Bader G G, Witt-Engerström I, Hagberg B (1989). Neurophysiological findings in the Rett syndrome, II: Visual and auditory brainstem, middle and late evoked responses. Brain Dev, 11(2): 110-114.
5. Belichenko N P, Belichenko P V, Mobley W C (2009a). Evidence for both neuronal cell autonomous and nonautonomous effects of methyl-CpG-binding protein 2 in the cerebral cortex of female mice with MeCP2 mutation. Neurobiol Dis, 34(1): 71-77.
6. Belichenko P V, Wright E E, Belichenko N P, Masliah E, Li H H, Mobley W C, Francke U (2009b). Widespread changes in dendritic and axonal morphology in Mecp2-mutant mouse models of Rett syndrome: evidence for disruption of neuronal networks. J Comp Neurol, 514(3): 240-258.
7. Calfa G, Hablitz J J, Pozzo-Miller L (2011). Network hyperexcitability in hippocampal slices from MeCP2 mutant mice revealed by voltagesensitive dye imaging. J Neurophysiol, 105(4): 1768-1784.
8. Chahrour M, Jung S Y, Shaw C, Zhou X, Wong S T C, Qin J, Zoghbi H Y (2008). MeCP2, a key contributor to neurological disease, activates and represses transcription. Science, 320(5880): 1224-1229.
9. Chahrour M, Zoghbi H Y (2007). The story of Rett syndrome: from clinic to neurobiology. Neuron, 56(3): 422-437.
10. Chao H T, Chen H, Samaco R C, Xue M, Chahrour M, Yoo J, Neul J L, Gong S, Lu H C, Heintz N, Ekker M, Rubenstein J L, Noebels J L, Rosenmund C, Zoghbi H Y (2010). Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes. Nature, 468(7321): 263-269.
11. Chao H T, Zoghbi H Y, Rosenmund C (2007). MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number. Neuron, 56(1): 58-65.
12. Chen R Z, Akbarian S, Tudor M, Jaenisch R (2001). Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat Genet, 27(3): 327-331.
13. Chen W G, Chang Q, Lin Y, Meissner A, West A E, Griffith E C, Jaenisch R, Greenberg M E (2003). Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science, 302(5646): 885-889.
14. Cheval H, Guy J, Merusi C, De Sousa D, Selfridge J, Bird A (2012). Postnatal inactivation reveals enhanced requirement for MeCP2 at distinct age windows. Hum Mol Genet, 21(17): 3806-3814.
15. Cohen S, Gabel HW, Hemberg M, Hutchinson A N, Sadacca L A, Ebert D H, Harmin D A, Greenberg R S, Verdine V K, Zhou Z, Wetsel W C, West A E, Greenberg M E (2011). Genome-wide activitydependent MeCP2 phosphorylation regulates nervous system development and function. Neuron, 72(1): 72-85.
16. Collins A L, Levenson J M, Vilaythong A P, Richman R, Armstrong D L, Noebels J L, David Sweatt J, Zoghbi H Y (2004). Mild overexpression of MeCP2 causes a progressive neurological disorder in mice. Hum Mol Genet, 13(21): 2679-2689.
17. Cull-Candy S, Brickley S, Farrant M (2001). NMDA receptor subunits: diversity, development and disease. Curr Opin Neurobiol, 11(3): 327-335.
18. D'Cruz J A, Wu C, Zahid T, El-Hayek Y, Zhang L, Eubanks J H (2010). Alterations of cortical and hippocampal EEG activity in MeCP2-deficient mice. Neurobiol Dis, 38(1): 8-16.
19. Dani V S, Chang Q, Maffei A, Turrigiano G G, Jaenisch R, Nelson S B (2005). Reduced cortical activity due to a shift in the balance between excitation and inhibition in a mouse model of Rett syndrome. Proc Natl Acad Sci USA, 102(35): 12560-12565.
20. Dani V S, Nelson S B (2009). Intact long-term potentiation but reduced connectivity between neocortical layer 5 pyramidal neurons in a mouse model of Rett syndrome. J Neurosci, 29(36): 11263-11270.
21. Derecki N C, Cronk J C, Lu Z, Xu E, Abbott S B G, Guyenet P G, Kipnis J (2012). Wild-type microglia arrest pathology in a mouse model of Rett syndrome. Nature, 484(7392): 105-109.
22. Fyffe S L, Neul J L, Samaco R C, Chao H T, Ben-Shachar S, Moretti P, McGill B E, Goulding E H, Sullivan E, Tecott L H, Zoghbi H Y (2008). Deletion of MeCP2 in Sim1-expressing neurons reveals a critical role for MeCP2 in feeding behavior, aggression, and the response to stress. Neuron, 59(6): 947-958.
23. Gandal M J, Edgar J C, Klook K, Siegel S J (2011). Gamma synchrony: Towards a translational biomarker for the treatment-resistant symptoms of schizophrenia. Neuropharmacology, 62(3): 1504-1518.
24. Gantz S C, Ford C P, Neve K A, Williams J T (2011). Loss of MeCP2 in substantia nigra dopamine neurons compromises the nigrostriatal pathway. J Neurosci, 31(35): 12629-12637.
25. Gemelli T, Berton O, Nelson E D, Perrotti L I, Jaenisch R, Monteggia L M (2006). Postnatal loss of methyl-CpG binding protein 2 in the forebrain is sufficient to mediate behavioral aspects of Rett syndrome in mice. Biol Psychiatry, 59(5): 468-476.
26. Goffin D, Allen M, Zhang L, Amorim M, Wang I T J, Reyes A R S, Mercado-Berton A, Ong C, Cohen S, Hu L, Blendy J A, Carlson G C, Siegel S J, Greenberg M E, Zhou Z (2012). Rett syndrome mutation MeCP2 T158A disrupts DNA binding, protein stability and ERP responses. Nat Neurosci, 15(2): 274-283.
27. Guy J, Gan J, Selfridge J, Cobb S, Bird A (2007). Reversal of neurological defects in a mouse model of Rett syndrome. Science, 315(5815): 1143-1147.
28. Guy J, Hendrich B, Holmes M, Martin J E, Bird A (2001). A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet, 27(3): 322-326.
29. Jian L, Nagarajan L, de Klerk N, Ravine D, Bower C, Anderson A, Williamson S, Christodoulou J, Leonard H (2006). Predictors of seizure onset in Rett syndrome. J Pediatr, 149(4): 542-547.
30. Jones P L, Veenstra G J, Wade P A, Vermaak D, Kass S U, Landsberger N, Strouboulis J, Wolffe A P (1998). Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet, 19(2): 187-191.
31. Kishi N, Macklis J D (2004). MECP2 is progressively expressed in postmigratory neurons and is involved in neuronal maturation rather than cell fate decisions. Mol Cell Neurosci, 27(3): 306-321.
32. Lewis J D, Meehan R R, Henzel W J, Maurer-Fogy I, Jeppesen P, Klein F, Bird A (1992). Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell, 69(6): 905-914.
33. Lioy D T, Garg S K, Monaghan C E, Raber J, Foust K D, Kaspar B K, Hirrlinger P G, Kirchhoff F, Bissonnette J M, Ballas N, Mandel G (2011). A role for glia in the progression of Rett's syndrome. Nature, 475(7357): 497-500.
34. Lonetti G, Angelucci A, Morando L, Boggio E M, Giustetto M, Pizzorusso T (2010). Early environmental enrichment moderates the behavioral and synaptic phenotype of MeCP2 null mice. Biol Psychiatry, 67(7): 657-665.
35. Marchetto M C N, Carromeu C, Acab A, Yu D, Yeo G W, Mu Y, Chen G, Gage F H, Muotri A R (2010). A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell, 143(4): 527-539.
36. McGraw C M, Samaco R C, Zoghbi H Y (2011). Adult neural function requires MeCP2. Science, 333(6039): 186.
37. Medrihan L, Tantalaki E, Aramuni G, Sargsyan V, Dudanova I, Missler M, Zhang W (2008). Early defects of GABAergic synapses in the brain stem of a MeCP2 mouse model of Rett syndrome. J Neurophysiol, 99(1): 112-121.
38. Moretti P, Levenson JM, Battaglia F, Atkinson R, Teague R, Antalffy B, Armstrong D, Arancio O, Sweatt J D, Zoghbi H Y (2006). Learning and memory and synaptic plasticity are impaired in a mouse model of Rett syndrome. J Neurosci, 26(1): 319-327.
39. Na E S, Nelson E D, Adachi M, Autry A E, Mahgoub MA, Kavalali E T, Monteggia L M (2012). A mouse model for MeCP2 duplication syndrome: MeCP2 overexpression impairs learning and memory and synaptic transmission. J Neurosci, 32(9): 3109-3117.
40. Nan X, Campoy F J, Bird A (1997). MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell, 88(4): 471-481.
41. Nan X, Ng H H, Johnson C A, Laherty C D, Turner BM, Eisenman R N, Bird A (1998). Transcriptional repression by the methyl-CpGbinding protein MeCP2 involves a histone deacetylase complex. Nature, 393(6683): 386-389.
42. Neul J L, Kaufmann WE, Glaze D G, Christodoulou J, Clarke A J, Bahi-Buisson N, Leonard H, Bailey M E S, Schanen N C, Zappella M, Renieri A, Huppke P, Percy A K, and the RettSearch Consortium (2010). Rett syndrome: revised diagnostic criteria and nomenclature. Ann Neurol, 68(6): 944-950.
43. Noutel J, Hong Y K, Leu B, Kang E, Chen C (2011). Experiencedependent retinogeniculate synapse remodeling is abnormal in MeCP2-deficient mice. Neuron, 70(1): 35-42.
44. Qiu Z, Sylwestrak E L, Lieberman D N, Zhang Y, Liu X Y, Ghosh A (2012). The Rett syndrome protein MeCP2 regulates synaptic scaling. J Neurosci, 32(3): 989-994.
45. Samaco R C, Mandel-Brehm C, Chao H T, Ward C S, Fyffe-Maricich S L, Ren J, Hyland K, Thaller C, Maricich S M, Humphreys P, Greer J J, Percy A, Glaze D G, Zoghbi H Y, Neul J L (2009). Loss of MeCP2 in aminergic neurons causes cell-autonomous defects in neurotransmitter synthesis and specific behavioral abnormalities. Proc Natl Acad Sci USA, 106(51): 21966-21971.
46. Shahbazian M, Young J, Yuva-Paylor L, Spencer C, Antalffy B, Noebels J, Armstrong D, Paylor R, Zoghbi H (2002). Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron, 35(2): 243-254.
47. Skene P J, Illingworth R S, Webb S, Kerr A R W, James K D, Turner D J, Andrews R, Bird A P (2010). Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state. Mol Cell, 37(4): 457-468.
48. Stauder J E A, Smeets E E J, van Mil S G M, Curfs L G M (2006). The development of visual- and auditory processing in Rett syndrome: an ERP study. Brain Dev, 28(8): 487-494.
49. Szulwach K E, Li X, Smrt R D, Li Y, Luo Y, Lin L, Santistevan N J, Li W, Zhao X, Jin P (2010). Cross talk between microRNA and epigenetic regulation in adult neurogenesis. J Cell Biol, 189(1): 127-141.
50. Taneja P, Ogier M, Brooks-Harris G, Schmid D A, Katz D M, Nelson S B (2009). Pathophysiology of locus ceruleus neurons in a mouse model of Rett syndrome. J Neurosci, 29(39): 12187-12195.
51. Tropea D, Giacometti E, Wilson N R, Beard C, McCurry C, Fu D D, Flannery R, Jaenisch R, Sur M (2009). Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice. Proc Natl Acad Sci USA, 106(6): 2029-2034.
52. Uhlhaas P J, Singer W (2010). Abnormal neural oscillations and synchrony in schizophrenia. Nat Rev Neurosci, 11(2): 100-113.
53. van Zundert B, Yoshii A, Constantine-Paton M (2004). Receptor compartmentalization and trafficking at glutamate synapses: a developmental proposal. Trends Neurosci, 27(7): 428-437.
54. Ward C S, Arvide EM, Huang TW, Yoo J, Noebels J L, Neul J L (2011). MeCP2 is critical within HoxB1-derived tissues of mice for normal lifespan. J Neurosci, 31(28): 10359-10370.
55. Weng S M, McLeod F, Bailey M E S, Cobb S R (2011). Synaptic plasticity deficits in an experimental model of Rett syndrome: long-term potentiation saturation and its pharmacological reversal. Neuroscience, 180: 314-321.
56. Wood L, Gray N W, Zhou Z, Greenberg M E, Shepherd G M G (2009). Synaptic circuit abnormalities of motor-frontal layer 2/3 pyramidal neurons in an RNA interference model of methyl-CpG-binding protein 2 deficiency. J Neurosci, 29(40): 12440-12448.
57. Wood L, Shepherd G M G (2010). Synaptic circuit abnormalities of motor-frontal layer 2/3 pyramidal neurons in a mutant mouse model of Rett syndrome. Neurobiol Dis, 38(2): 281-287.
58. Wu H, Tao J, Chen P J, Shahab A, Ge W, Hart R P, Ruan X, Ruan Y, Sun Y E (2010). Genome-wide analysis reveals methyl-CpG-binding protein 2-dependent regulation of microRNAs in a mouse model of Rett syndrome. Proc Natl Acad Sci USA, 107(42): 18161-18166.
59. Young J I, Hong E P, Castle J C, Crespo-Barreto J, Bowman A B, Rose M F, Kang D, Richman R, Johnson J M, Berget S, Zoghbi H Y (2005). Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2. Proc Natl Acad Sci USA, 102(49): 17551-17558.
60. Zhang Z W, Zak J D, Liu H (2010). MeCP2 is required for normal development of GABAergic circuits in the thalamus. J Neurophysiol, 103(5): 2470-2481.
61. Zhou Z, Hong E J, Cohen S, Zhao W N, Ho H Y H, Schmidt L, Chen W G, Lin Y, Savner E, Griffith E C, Hu L, Steen J A, Weitz C J, Greenberg M E (2006). Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation. Neuron, 52(2): 255-269.
62. Zoghbi H Y (2003). Postnatal neurodevelopmental disorders: meeting at the synapse? Science, 302(5646): 826-830.